Evidence map›Paper›PMID 41057316›Full record

ArticleBlood cancer journal2025

Outcomes of older patients with TP53-mutated myeloid neoplasms.

Omer Jamy, Mobachir El Kettani, Kashish Shah, Rory M Shallis, Kendall Diebold, Alexander Coltoff, Aaron D Goldberg, Anand Patel, Jan P Bewersdorf, Charles Foucar and 9 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood cancer journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Omer JamyDivision of Hematology and Oncology, The University of Alabama at Birmingham, Birmingham, AL, USA.
Mobachir El KettaniDivision of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapy Program, Mayo Clinic, Jacksonville, FL, USA.
Kashish ShahDivision of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapy Program, Mayo Clinic, Jacksonville, FL, USA.
Rory M ShallisSection of Medical Oncology and Hematology, Department of Internal Medicine, Yale School of Medicine and Yale Comprehensive Cancer Center, New Haven, CT, USA.
Kendall DieboldDivision of Hematology and Oncology, The University of Alabama at Birmingham, Birmingham, AL, USA.
Alexander ColtoffDivision of Hematology and Oncology, Medical University of South Carolina, Charleston, SC, USA.
Aaron D GoldbergLeukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Anand PatelSection of Hematology and Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA.ORCID http://orcid.org/0000-0002-0296-8686
Jan P BewersdorfSection of Medical Oncology and Hematology, Department of Internal Medicine, Yale School of Medicine and Yale Comprehensive Cancer Center, New Haven, CT, USA.ORCID http://orcid.org/0000-0003-3352-0902
Charles FoucarDivision of Hematology and Oncology, University of New Mexico Comprehensive Cancer Center, Albuquerque, NM, USA.
Yasmin AbazaRobert H. Lurie Comprehensive Cancer Center, Northwestern Hospital, Chicago, IL, USA.ORCID http://orcid.org/0000-0002-9156-7912
Neil PalmisianoDivision of Hematology and Oncology, Rutgers Cancer Institute, New Brunswick, NJ, USA.
Adam S DuVallSection of Hematology and Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA.ORCID http://orcid.org/0000-0002-9163-8792
Vamsi KotaDivision of Hematology and Oncology, Augusta University, Augusta, GA, USA.ORCID http://orcid.org/0000-0002-5290-9289
Shyam A PatelDepartment of Medicine-Division of Hematology/Oncology, UMass Memorial Medical Center, UMass Chan Medical School, Worcester, MA, USA.ORCID http://orcid.org/0000-0002-8208-1902
Amer M ZeidanSection of Medical Oncology and Hematology, Department of Internal Medicine, Yale School of Medicine and Yale Comprehensive Cancer Center, New Haven, CT, USA.
Ehab AtallahDivision of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.
Mark R LitzowDivision of Hematology, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0002-9816-6302
Talha BadarDivision of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapy Program, Mayo Clinic, Jacksonville, FL, USA. badar.talha@mayo.edu.ORCID http://orcid.org/0000-0003-1548-918X

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41057316
PMCPMC12504439

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.